نتایج جستجو برای: bhk rabies vaccine

تعداد نتایج: 116080  

Journal: :Applied microbiology 1974
V J Cabasso M B Dobkin R E Roby A H Hammar

An experimentally killed rabies virus vaccine prepared in a human diploid cell strain (WI-38)-Wyeth rabies vaccine (WRV)-was used by various injection schedules in two separate studies to define more closely in human volunteer subjects an effective vaccination schedule for pre- or postexposure immunization, particularly for donors of rabies-hyperimmune plasma. To permit valid comparisons betwee...

2006
Ad Vos Orhan Aylan Roland Estrada

Effective control of terrestrial wildlife rabies seemed almost impossible in Europe until the development of oral vaccination. Nowadays, oral vaccination of foxes (Vulpes vulpes) by distributing vaccine baits is the method of choice in rabies control in most European countries. Consequently, large areas are now rabies-free and here baits are no longer distributed or the distribution of baits is...

Journal: :Applied microbiology 1970
J F Lavender

A 10% suckling rat brain rabies vaccine free from encephalitogenic activity was prepared and inactivated with 1:8,000 beta-propiolactone (BPL), or ultraviolet light, or a combination of ultraviolet light and BPL, or 1% phenol. Potency was excellent in all samples, with the exception of the phenolized product which was marginal. A purified suckling rat brain (SRB) vaccine prepared by zonal centr...

2013
Haixue Zheng Jianhong Guo Ye Jin Fan Yang Jijun He Lv Lv Kesan Zhang Qiong Wu Xiangtao Liu Xuepeng Cai

BACKGROUND No licensed vaccine is currently available against serotype A foot-and-mouth disease (FMD) in China, despite the isolation of A/WH/CHA/09 in 2009, partly because this strain does not replicate well in baby hamster kidney (BHK) cells. METHODOLOGY/PRINCIPAL FINDINGS A novel plasmid-based reverse genetics system was used to construct a chimeric strain by replacing the P1 gene in the v...

2015
Manjunatha Muniswamappa Venkataswamy Shampur Narayan Madhusudana Sampada Sudarshan Sanyal Shaheen Taj Ashwin Yajaman Belludi Reeta Subramaniam Mani Nandita Hazra

PURPOSE Immunization against rabies in humans induces protective neutralizing antibodies; however, the induction of type 1 or type 2 cytokine mediated cellular immune responses following rabies vaccination is not understood. Hence, the present study investigated cellular cytokine responses in vaccinated individuals. MATERIALS AND METHODS The study groups included healthy rabies antigen naive ...

2008
Luis Souza Lima de Souza Reis Neuza Maria Frazatti-Gallina Rosana de Lima Paoli Rogerio Giuffrida Avelino Albas Eunice Oba Paulo Eduardo Pardo

This study evaluated the effect of Matricaria chamomilla and vaccination frequency on cattle immunization against rabies. Four groups (n = 15 /group) were treated with or without Matricaria chamomilla CH12 and vaccinated with one or two doses of rabies vaccine (30 day interval). No effect of chamomile was found on cattle immunization against rabies; however, antibody titers were protective in c...

2010
John Lusingu Ally Olotu Amanda Leach Marc Lievens Johan Vekemans Aurélie Olivier Sarah Benns Raimos Olomi Salum Msham Trudie Lang Jayne Gould Karin Hallez Yolanda Guerra Patricia Njuguna Ken O. Awuondo Anangisye Malabeja Omar Abdul Samwel Gesase Denise Dekker Lincoln Malle Sadiki Ismael Neema Mturi Chris J. Drakeley Barbara Savarese Tonya Villafana W. Ripley Ballou Joe Cohen Eleanor M. Riley Martha M. Lemnge Kevin Marsh Philip Bejon Lorenz von Seidlein

The malaria vaccine candidate, RTS,S/AS01(E), showed promising protective efficacy in a trial of Kenyan and Tanzanian children aged 5 to 17 months. Here we report on the vaccine's safety and tolerability. The experimental design was a Phase 2b, two-centre, double-blind (observer- and participant-blind), randomised (1∶1 ratio) controlled trial. Three doses of study or control (rabies) vaccines w...

2014
Philippe Mähl Florence Cliquet Anne-Laure Guiot Enel Niin Emma Fournials Nathalie Saint-Jean Michel Aubert Charles E Rupprecht Sylvie Gueguen

The SAG2 vaccine (RABIGEN® SAG2) is a modified live attenuated rabies virus vaccine, selected from the SAD Bern strain in a two-step process of amino acid mutation using neutralizing monoclonal antibodies. The strain is genetically stable and does not spread in vivo or induce a persistent infection. Its absence of residual pathogenicity was extensively demonstrated in multiple target and non ta...

2017
Ben Stading James A Ellison William C Carson Panayampalli Subbian Satheshkumar Tonie E Rocke Jorge E Osorio

Rabies is an ancient neglected tropical disease that causes tens of thousands of human deaths and millions of cattle deaths annually. In order to develop a new vaccine for potential use in bats, a reservoir of rabies infection for humans and animals alike, an in silico antigen designer tool was used to create a mosaic glycoprotein (MoG) gene using available sequences from the rabies Phylogroup ...

2011
Do Manh Hung Le Van Tuan

Background Human rabies fatal cases were related to animal rabies but it is reported that often lacks of animal rabies data, human case is underreported and rabies immune globulin and vaccine are not available so that these contributed to raise the big issues for rabies control and prevention measures in the developing countries. Recently in central coast region of Viet Nam human rabies fatal c...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید